Illinois CancerCare - Bloomington, Bloomington
University of Illinois Hospital and Health Sciences System (Outpatient Cancer Center), Chicago
University of Illinois Hospital and Health Sciences System, Chicago
и още 10

Набиране на участнициФаза 3

Възраст 18 и повече · Всички полове · Обновено на 25.09.2026 г. · NCT07222566

A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202)

University of Illinois Chicago, Chicago
Illinois Cancer Specialists, Niles

Набиране на участнициФаза 3

Възраст от 18 до 100 · Всички полове · Обновено на 25.09.2026 г. · NCT05920356

Symbiotic-Lung-10: A Study to Learn About PF-08634404 Alone or in Combination in Early-stage or Locally Advanced NSCLC

Hope and Healing Clinical Research, Hinsdale
Hope and Healing Clinical Research, New Lenox

Набиране на участнициФаза 2

Възраст 18 и повече · Всички полове · Обновено на 25.09.2026 г. · NCT07489066

This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.

Endeavor Health, Elmhurst
Hope and Healing Cancer Services, Hinsdale
Advocate Medical Group - Libertyville Oncology, Libertyville
и още 4

Набиране на участнициФаза 3

Възраст 18 и повече · Всички полове · Обновено на 25.09.2026 г. · NCT06758401

A Study to Investigate Ubamatamab With and Without Marlotamig (REGN7075) in Adult Participants With Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC)

Rush University Medical Center, Chicago
University of Illinois Chicago, Chicago

Набиране на участнициФаза 2

Възраст 18 и повече · Всички полове · Обновено на 25.09.2026 г. · NCT07154290

A Registry for People With Lung Cancer

Rush University Medical Center (Data collection only), Chicago
Endeavor Health, Evanston

Набиране на участнициНаблюдателно проучване

Възраст 18 и повече · Всички полове · Обновено на 24.09.2026 г. · NCT06424327

A Study to Compare the Combination of Navlimetostat (BMS-986504) With Pembrolizumab and Chemotherapy Versus Placebo Plus Pembrolizumab and Chemotherapy in First-line Metastatic Non-small Cell Lung Cancer Participants With Homozygous MTAP Deletion

Local Institution - 0605, Decatur

Набиране на участнициФаза 2/3

Възраст 18 и повече · Всички полове · Обновено на 23.09.2026 г. · NCT07063745

Neoadjuvant and Adjuvant Treatment in Resectable Non-small Cell Lung Cancer

Research Site, Chicago

Набиране на участнициФаза 2

Възраст от 18 до 95 · Всички полове · Обновено на 23.09.2026 г. · NCT05061550

Study of Izalontamab Brengitecan (BMS-986507) Versus Platinum-Pemetrexed for EGFR-mutated Non-small Cell Lung Cancer After Failure of EGFR TKI Therapy (IZABRIGHT-Lung01)

Rush University Medical Center, Chicago

Набиране на участнициФаза 2/3

Възраст 18 и повече · Всички полове · Обновено на 22.09.2026 г. · NCT07100080

Testing the Combination of an Anti-cancer Drug, Iadademstat, With Other Anti-cancer Drugs (Atezolizumab or Durvalumab) at Improving Outcomes for Small Cell Lung Cancer

University of Chicago Comprehensive Cancer Center, Chicago
UC Comprehensive Cancer Center at Silver Cross, New Lenox
University of Chicago Medicine-Orland Park, Orland Park

Набиране на участнициФаза 1/2

Възраст 18 и повече · Всички полове · Обновено на 17.09.2026 г. · NCT06287775

Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors

University of Illinois Cancer Center, Chicago
University of Chicago Medicine, Chicago
City of Hope - Chicago, Zion

Набиране на участнициФаза 1

Възраст 18 и повече · Всички полове · Обновено на 10.09.2026 г. · NCT06293898

A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer

Affiliated Oncologists, LLC, Chicago Ridge
City of Hope® Cancer Center Chicago, Zion

Набиране на участнициФаза 3

Възраст 18 и повече · Всички полове · Обновено на 8.09.2026 г. · NCT06793215

A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer

University of Illinois at Chicago, Chicago
University of Chicago Hospital, Chicago
Springfield Clinic Main Campus, Springfield

Набиране на участнициФаза 3

Възраст 18 и повече · Всички полове · Обновено на 8.09.2026 г. · NCT06119581

A Study of LY4050784 in Participants With Advanced or Metastatic Solid Tumors

University of Chicago, New Lenox

Набиране на участнициФаза 1

Възраст 18 и повече · Всички полове · Обновено на 8.09.2026 г. · NCT06561685

Open-label Study of BBO-8520 in Adult Subjects With KRASG12C Non-small Cell Lung Cancer

OSF Saint Francis Medical Center, Peoria

Набиране на участнициФаза 1

Възраст 18 и повече · Всички полове · Обновено на 3.09.2026 г. · NCT06343402

Study to Evaluate Efficacy and Safety of Firmonertinib Compared With Investigator's Choice of EGFR Inhibitor as First-Line Treatment in Participants Who Have Locally Advanced or Metastatic NSCLC With EGFR P-Loop and Alpha C-Helix Compressing (PACC) Uncommon Mutations

Illinois Cancer Specialists, Arlington Heights
University of Illinois Hospital and Health Sciences Systems, Chicago

Набиране на участнициФаза 3

Възраст 18 и повече · Всички полове · Обновено на 1.09.2026 г. · NCT07185997

Safety and Efficacy of BNT327, an Investigational Therapy in Combination With Chemotherapy for Patients With Untreated Small-cell Lung Cancer

Illinois Cancer Specialists, Niles

Набиране на участнициФаза 3

Възраст 18 и повече · Всички полове · Обновено на 1.09.2026 г. · NCT06712355

Testing Proton Craniospinal Radiation Therapy Versus the Usual Radiation Therapy for Leptomeningeal Metastasis, RADIATE-LM Trial

Alton Memorial Hospital, Alton
Northwestern University, Chicago
Northwestern Medicine Cancer Center Kishwaukee, DeKalb
и още 3

Набиране на участнициФаза 3

Възраст 18 и повече · Всички полове · Обновено на 17.08.2026 г. · NCT06500481

Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer

Rush-Copley Medical Center, Aurora
Advocate Outpatient Center - Aurora, Aurora
Advocate Good Shepherd Hospital, Barrington
и още 46

Набиране на участнициФаза 3

Възраст 18 и повече · Всички полове · Обновено на 17.08.2026 г. · NCT05624996

Study Evaluating the Safety and Efficacy of HWK-007, a PTK7-directed Antibody Drug Conjugate in Participants With Advanced Solid Tumors

St. Francis Medical Center (OSF Healthcare), Peoria

Набиране на участнициФаза 1

Възраст 18 и повече · Всички полове · Обновено на 5.08.2026 г. · NCT07444814

Study of XmAb®819 in Subjects With Advanced Clear Cell Renal Cell Carcinoma

Xencor Investigative Site, Chicago
Xencor Investigative Site, Chicago

Набиране на участнициФаза 1

Възраст 18 и повече · Всички полове · Обновено на 3.08.2026 г. · NCT05433142

Evaluate the Clinical Performance of the Flow Cytometry - FlowPath Lung Test as a Sensitive and Specific Non-invasive Diagnostic of Sputum Samples to Identify/Detect the Presence of Lung Cancer in High-risk Individuals Who Have Existing Lung Nodules, 6 to <30 mm in Diameter, Determined by LDCT.

Captain James A. Lovell Federal Health Care Center, North Chicago

Набиране на участници

Възраст от 50 до 80 · Всички полове · Обновено на 16.07.2026 г. · NCT07168993

CARE Tool Study Aim 3

Alton Memorial Hospital, Alton

Набиране на участници

Възраст 18 и повече · Всички полове · Обновено на 8.07.2026 г. · NCT07296887

Integrated Cancer Repository for Cancer Research

Rush-Copley Cancer Care Center, Aurora
Rush-Copley Healthcare Center, Yorkville

Набиране на участнициНаблюдателно проучванеЗдравите доброволци са добре дошли

Възраст от 19 до 110 · Всички полове · Обновено на 29.06.2026 г. · NCT02012699

Autologous LN-145 in Patients With Metastatic Non-Small-Cell Lung Cancer

Advocate Aurora Health, Park Ridge

Набиране на участнициФаза 2

Възраст от 18 до 70 · Всички полове · Обновено на 26.06.2026 г. · NCT04614103

A Study Evaluating The Combination of Immunotherapy With Radiotherapy in Non-Small Cell Lung Cancer

o University of Chicago Medicine Comprehensive Cancer Center, Chicago

Набиране на участнициФаза 2

Възраст 18 и повече · Всички полове · Обновено на 16.06.2026 г. · NCT07603856

Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)

Advocate Good Shepherd Hospital, Barrington
Illinois CancerCare-Bloomington, Bloomington
Illinois CancerCare-Canton, Canton
и още 47

Набиране на участнициФаза 2

Възраст 18 и повече · Всички полове · Обновено на 3.06.2026 г. · NCT05642572

Stereotactic Body Radiation Therapy Planning With Artificial Intelligence-Directed Dose Recommendation for Treatment of Primary or Metastatic Lung Tumors, RAD-AI Study

Northwestern University, Chicago

Набиране на участници

Възраст 18 и повече · Всички полове · Обновено на 29.05.2026 г. · NCT05802186

A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements

University of Chicago, Chicago

Набиране на участнициФаза 1/2

Възраст 12 и повече · Всички полове · Обновено на 27.05.2026 г. · NCT03093116

От ClinicalTrials.gov, данни към 5.10.2026 г.. Всяко проучване има свои критерии за участие; екипът на проучването определя кой може да се включи.